Mostrar el registro sencillo del ítem

Artículo

dc.creatorGómez Arboledas, Ángelaes
dc.creatorDávila Cansino, José Carloses
dc.creatorSánchez Mejías, Elisabethes
dc.creatorNavarro Garrido, Victoriaes
dc.creatorNúñez Díaz, Cristinaes
dc.creatorSánchez Varo, Raquel Maríaes
dc.creatorSánchez Mico, Maríaes
dc.creatorVizuete Chacón, María Luisaes
dc.creatorVitorica Ferrández, Francisco Javieres
dc.creatorGutiérrez Pérez, Antoniaes
dc.date.accessioned2022-07-11T08:42:23Z
dc.date.available2022-07-11T08:42:23Z
dc.date.issued2018
dc.identifier.citationGómez Arboledas, Á., Dávila Cansino, J.C., Sánchez Mejías, E., Navarro Garrido, V., Núñez Díaz, C., Sánchez Varo, R.M.,...,Gutiérrez Pérez, A. (2018). Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease. Glia, 66 (3), 637-653.
dc.identifier.issn0894-1491es
dc.identifier.issn1098-1136es
dc.identifier.urihttps://hdl.handle.net/11441/135193
dc.description.abstractReactive astrogliosis, a complex process characterized by cell hypertrophy and upregulation ofcomponents of intermediate filaments, is a common feature in brains of Alzheimer’s patients. Reac-tive astrocytes are found in close association with neuritic plaques; however, the precise role ofthese glial cells in disease pathogenesis is unknown. In this study, using immunohistochemical tech-niques and light and electron microscopy, we report that plaque-associated reactive astrocytesenwrap, engulf and may digest presynaptic dystrophies in the hippocampus of amyloid precursorprotein/presenilin-1 (APP/PS1) mice. Microglia, the brain phagocytic population, was apparentlynot engaged in this clearance. Phagocytic reactive astrocytes were present in 35% and 67% ofamyloid plaques at 6 and 12 months of age, respectively. The proportion of engulfed dystrophicneurites was low, around 7% of total dystrophies around plaques at both ages. This fact, alongwith the accumulation of dystrophic neurites during disease course, suggests that the efficiency ofthe astrocyte phagocytic process might be limited or impaired. Reactive astrocytes surroundingand engulfing dystrophic neurites were also detected in the hippocampus of Alzheimer’spatientsby confocal and ultrastructural analysis. We posit that the phagocytic activity of reactive astrocytesmight contribute to clear dysfunctional synapses or synaptic debris, thereby restoring impairedneural circuits and reducing the inflammatory impact of damaged neuronal parts and/or limitingthe amyloid pathology. Therefore, potentiation of the phagocytic properties of reactive astrocytesmay represent a potential therapy in Alzheimer s disease.es
dc.description.sponsorshipFondo de Investigación Sanitaria (FIS). Instituto de Salud Carlos III (ISCiii) de España y fondos FEDER de la Unión Europea. PI15/00796 y PI15/00957es
dc.description.sponsorshipFundación La Marató-TV3 de Cataluña, España. 20141432, 20141431, 20141433, y 20141430es
dc.description.sponsorshipCentro de investigación en red de enfermedades neurodegenerativas (CIBERNED) de España. PI2015-2/02es
dc.description.sponsorshipJunta de Andalucía. Proyecto de Excelencia CTS-2035es
dc.formatapplication/pdfes
dc.format.extent17 p.es
dc.language.isoenges
dc.publisherWileyes
dc.relation.ispartofGlia, 66 (3), 637-653.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAlzheimer’s diseasees
dc.subjectneurodegenerationes
dc.subjectneuropathologyes
dc.subjectreactive astrocytees
dc.subjectsynaptopathyes
dc.titlePhagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's diseasees
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Bioquímica y Biología Moleculares
dc.relation.projectIDPI15/00796es
dc.relation.projectIDPI15/00957es
dc.relation.projectIDCTS-2035es
dc.relation.publisherversionhttps://doi.org/10.1002/glia.23270es
dc.identifier.doi10.1002/glia.23270es
dc.journaltitleGliaes
dc.publication.volumen66es
dc.publication.issue3es
dc.publication.initialPage637es
dc.publication.endPage653es
dc.contributor.funderInstituto de Salud Carlos IIIes
dc.contributor.funderEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)es
dc.contributor.funderFundación La Marató-TV3. Cataluña. Españaes
dc.contributor.funderJunta de Andalucíaes

FicherosTamañoFormatoVerDescripción
Glia - 2017 - Gomez‐Arboledas - ...3.577MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional